Newsroom
For media inquiries, please contact 340B Health Senior Vice President of Communications Jon Tilton at jon.tilton@340bhealth.org or 202-536-2285.
-
MEDPAC REPORT FINDS NO SIGNIFICANT LINK BETWEEN 340B AND HIGHER CANCER DRUG SPENDING
-
MEDICARE SURVEY STRATEGY TO CUT 340B PAYMENT IS CONTRARY TO LAW AND WILL HARM THE SAFETY NET
-
Sunlight Disinfects — And Helps Lower Drug Costs
-
STATEMENT REGARDING CMS ANNOUNCEMENT ON 340B HOSPITAL DRUG COST SURVEY
-
Ohio lawmakers aim to protect 340B hospitals from PBM price manipulations
-
STATEMENT REGARDING GAO REPORT ON DUPLICATE DISCOUNTS
-
STATEMENT REGARDING MEDICARE PAYMENT ADVISORY COMMISSION ANALYSIS OF 340B HOSPITAL DRUG SPENDING
-
MedPAC finds 340B effect on pricing ‘modest,’ going against pharma critique
-
STATEMENT REGARDING GAO REPORT ON 340B HOSPITAL CONTRACTS
-
STATEMENT REGARDING CMS BULLETIN ON 340B DUPLICATE DISCOUNTS IN MEDICAID
-
High cost of insulin is sparking worries, political activism
-
How 5 health systems are using their 340B savings